Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
21.51
+0.69 (3.31%)
Jan 21, 2025, 4:00 PM EST - Market closed
Phibro Animal Health Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for PAHC stock have an average target of 20.5, with a low estimate of 15 and a high estimate of 25. The average target predicts a decrease of -4.70% from the current stock price of 21.51.
Analyst Consensus: Sell
* Price targets were last updated on Dec 17, 2024.
Analyst Ratings
The average analyst rating for PAHC stock from 4 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 2 | 2 | 1 | 2 | 2 |
Sell | 2 | 2 | 2 | 2 | 2 | 2 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 3 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Morgan Stanley | Morgan Stanley | Hold Maintains $20 → $25 | Hold | Maintains | $20 → $25 | +16.23% | Dec 17, 2024 |
Barclays | Barclays | Sell Maintains $13 → $20 | Sell | Maintains | $13 → $20 | -7.02% | Nov 12, 2024 |
JP Morgan | JP Morgan | Hold Initiates $22 | Hold | Initiates | $22 | +2.28% | Sep 10, 2024 |
B of A Securities | B of A Securities | Sell Maintains $13 → $15 | Sell | Maintains | $13 → $15 | -30.26% | Aug 30, 2024 |
Barclays | Barclays | Sell Maintains $10 → $13 | Sell | Maintains | $10 → $13 | -39.56% | May 10, 2024 |
Financial Forecast
Revenue This Year
1.30B
from 1.02B
Increased by 27.25%
Revenue Next Year
1.48B
from 1.30B
Increased by 14.13%
EPS This Year
1.67
from 0.06
Increased by 2,700.18%
EPS Next Year
2.03
from 1.67
Increased by 21.53%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 1.5B | 1.6B | 1.6B | ||
Avg | 1.3B | 1.5B | 1.5B | ||
Low | 1.1B | 1.4B | 1.4B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 48.7% | 20.8% | 8.7% | ||
Avg | 27.3% | 14.1% | 3.1% | ||
Low | 4.2% | 5.0% | -5.7% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 1.90 | 2.14 | 2.69 |
Avg | 1.67 | 2.03 | 2.30 |
Low | 1.43 | 1.89 | 2.01 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 3,086.2% | 28.2% | 32.4% |
Avg | 2,700.2% | 21.5% | 13.2% |
Low | 2,298.7% | 13.2% | -1.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.